Home » Topics » Regulatory

Regulatory
RSS

Glaxo Wellcome launches Flovent for pediatric asthma in U.S.

April 28, 1998

Glaxo Wellcome seeks approval for combination asthma product

April 28, 1998

New antiglaucoma agent approved in U.S.

April 24, 1998

Abbott's vitamin D analogue approved for secondary hyperparathyroidism

April 24, 1998

Searle introduces new formulation of verapamil hydrochloride in Canada

April 23, 1998

First marketing approval for Novartis transplant drug

April 22, 1998

FDA clears new indication for Prevacid

April 17, 1998

Cosopt receives marketing approval from FDA

April 16, 1998

Antiviral drugs advisory committee will discuss Intron A/Rebetol NDA

April 15, 1998

FDA approves fifth indication for Neupogen

April 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....